From biomarker-driven breakthroughs to AI-powered early detection and a renewed commitment to equity and patient centricity, the past 12 months have seen major strides across cancer research, treatment, and communication. At Inizio, we’ve had a front-row seat to this transformation, supporting over 140 oncology assets in 2024 alone and contributing to 95% of the top 20 oncology product launches. 

Here, we reflect on five key themes that have shaped our work and the wider oncology space over the past year. 

1. Biomarkers: The engine of personalized cancer care

Biomarker science has been rapidly transforming how cancer is diagnosed and treated. With increasing ability to identify molecular signatures, clinicians can prescribe targeted therapies with greater precision, delivering better outcomes for patients with historically treatment-resistant cancers. 

“It’s an exciting time in the evolution of biomarkers. The way we now treat conditions such as non-small cell lung cancer (NSCLC) and metastatic breast cancer – in which the survival rate was often less than a year – has improved considerably. And that’s due to a greater understanding of the biomarkers that allow us to identify molecular signatures and create personalised therapies.” – David Segarnick PhD, Chief Medical Officer and Executive Vice Presi